Mereo BioPharma Group plc (MREO) Misses Q2 EPS by 1c

Mereo BioPharma Group plc (NASDAQ: MREO) reported Q2 EPS of ($0.02), $0.01 worse than the analyst estimate of ($0.01).

For earnings history and earnings-related data on Mereo BioPharma Group plc (MREO) click here.

You May Also Be Interested In

• BofA maintains underperform ratings on six BDC stocks
• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• BofA says CTA Treasury shorts stable, euro short-cover risk rises